Tag: Psoriasis
Long-Term Tx Adherence Low in Mild-to-Moderate Psoriasis
Internet-based reporting intervention improves adherence to treatment with topical fluocinonide
Study Compares Effectiveness of Biologics in Psoriasis Treatment
Ustekinumab had highest effectiveness during five years of tx; more dose escalation for etanercept
Coronary Artery Calcium Increased in Psoriasis Patients
Higher levels of coronary artery calcium in patients with psoriasis similar to that seen in type 2 diabetes
Psoriasis Patients at Higher Risk for Other Health Issues
Inflammatory effects of disease can impact entire body, expert says
Perceived Stigmatization Common for Patients With Psoriasis
Lower education, higher disease visibility, severity, duration, Type D personality tied to stigmatization
Psoriasis-Tailored Interview Training Beneficial for Clinicians
Psoriasis + Well-being training significantly improves clinicians' motivational interview skills, knowledge
Ixekizumab Efficacious for Psoriasis Over 60 Weeks
Four in five patients saw at least a 75 percent improvement in symptoms
Genetic Variants ID Treatment Response in Psoriasis
Ten SNPs presented that correlate with treatment responses to anti-TNF-α agents
Research Finds Link Between Psoriasis, Obesity, T2DM
A genetic link is one theory for the possible association, researchers say
Ustekinumab More Effective Than TNF-α Inhibitors in Psoriasis
Ustekinumab more effective than three tumor necrosis factor-α-inhibitors at six, 12 months
